Intracellular calcium chelator BAPTA protects cells against toxic calcium overload but also alters physiological calcium responses

被引:37
作者
Collatz, MB [1 ]
Rudel, R [1 ]
Brinkmeier, H [1 ]
机构
[1] UNIV ULM,ALLGEMEINE PHYSIOL ABT,D-89069 ULM,GERMANY
关键词
D O I
10.1016/S0143-4160(97)90056-7
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The effect of the membrane-permeant calcium chelator 1,2-bis-(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid tetra(acetoxymethyl) ester (BAPTA/AM) on ionomycin-induced cellular calcium overload was studied in single differentiated NH15-CA2 neuroblastoma x glioma hybrid cells. To monitor [Ca2+](i), we used the fluorescent indicator Fura-2. Preincubation of the cells with 3 mu M BAPTA/AM reduced the number of cells showing deregulation of [Ca2+](i) during ionomycin-induced calcium influx. The calcium transients elicited by application of KCI were also severely affected by the chelator. These transients, although varying from cell to cell in shape, amplitude and duration, are well reproducible in individual cells. After incubation of cells for 1 h with 0.3-30 mu m BAPTA/AM the time course of these cellular transients was markedly slowed. At 1 mu M BAPTA/AM, the time constant of decline of [Ca2+](i) was increased by a factor of 4.1 +/- 2.4 (n = 14) and the amplitude was reduced to about 50%. With 30 mu M BAPTA/AM, the K+-induced calcium transients were almost completely inhibited. We conclude that intracellularly loaded calcium chelators may be used for the prevention of [Ca2+](i)-induced cell damage, however, at the expense of a disturbed calcium signalling.
引用
收藏
页码:453 / 459
页数:7
相关论文
共 30 条
[1]  
APPEL SH, 1991, CURRENT NEUROLOGY, V11, P287
[2]   Ether lipid-induced cell damage of neuroblastoma cells is only weakly correlated with increased intracellular Ca2+ levels [J].
Brinkmeier, H ;
Schneider, M ;
Rudel, R .
CELL CALCIUM, 1996, 19 (05) :383-390
[3]  
COLLATZ MB, 1996, J MUSCLE RES CELL M, V17, P378
[4]  
EIMERL S, 1994, J NEUROCHEM, V62, P1223
[5]   AMYOTROPHIC-LATERAL-SCLEROSIS IS A MULTIFACTORIAL DISEASE [J].
EISEN, A .
MUSCLE & NERVE, 1995, 18 (07) :741-752
[6]   PARVALBUMIN IS A MARKER OF ALS-RESISTANT MOTOR-NEURONS [J].
ELLIOTT, JL ;
SNIDER, WD .
NEUROREPORT, 1995, 6 (03) :449-452
[7]   CALCULATION AND CONTROL OF FREE DIVALENT-CATIONS IN SOLUTIONS USED FOR MEMBRANE-FUSION STUDIES [J].
FOHR, KJ ;
WARCHOL, W ;
GRATZL, M .
METHODS IN ENZYMOLOGY, 1993, 221 :149-157
[8]  
HAMM S, 1997, IN PRESS PFLUGERS AR
[9]  
HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P316
[10]   PARVALBUMIN AND CALBINDIN D-28K IN THE HUMAN MOTOR SYSTEM AND IN MOTOR-NEURON DISEASE [J].
INCE, P ;
STOUT, N ;
SHAW, P ;
SLADE, J ;
HUNZIKER, W ;
HEIZMANN, CW ;
BAIMBRIDGE, KG .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1993, 19 (04) :291-299